Diagnosing Lynch syndrome: Is the answer in the mouth?

Gut

Volumn 52, Issue 12, 2003, Pages 1665-1667

  Roy, H K ^a   Lynch, H T ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; COLON CANCER; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; GENE MUTATION; GENETIC PREDISPOSITION; GEOMETRY; HEREDITY; HUMAN; HYPERTROPHY; MICROSATELLITE INSTABILITY; MOUTH LESION; NON INVASIVE MEASUREMENT; NOTE; PATHOGENESIS; PHENOTYPE; PIGMENT EPITHELIUM; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; MOUTH MUCOSA;

EID: 0344234250     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.52.12.1665     Document Type: Note

References (28)

1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
2. Grady WM. Genetic testing for high-risk colon cancer patients. Gastroenterology 2003;124:1574-94.
3. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003;138:560-70.
4. Schroy PC 3rd, Barrison AF, Ling BS, et al. amily history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 2002;97:1031-6.
5. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997;113:1146-58.
6. Syngal S, Fox EA, Eng C, et al. Sensitivity and specificity of clinical criteria for hereditary nonpolyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000;37:641-5.
7. Desai DC, Lockman JC, Chadwick RB, et al. Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet 2000;37:646-52.
8. Goodfellow PJ, Buttin BM, Herzog TJ, et al. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci U S A 2003;100:5908-13.
9. Wagner A, Barrows A, Wijnen JT, et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 2003;72:1088-100.
10. Jarvinen HJ, Aarnio M. Surveillance on mutation carriers of DNA mismatch repair genes. Ann Chir Gynaecol 2000;89:207-10.
11. Rijcken FE, Hollema H, Kleibeuker JH. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002;50:382-6.
12. Goel A, Arnold CN, Niedzwiecki D, et al. Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 2003;63:1608-14.
13. Ricciardiello L, Goel A, Mantovani V, et al. Frequent loss of hMLH1 by promoter hypermethylation leads to microsatellite instability in adenomatous polyps of patients with a single first-degree member affected by colon cancer. Cancer Res 2003;63:787-92.
14. Reyes CM, Allen BA, Terdiman JP, et al. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer 2002;95:1848-56.
15. King JE, Dozois RR, Lindor NM, et al. Care of patients and their families with familial adenomatous polyposis. Mayo Clin Proc 2000;75:57-67.
16. Sieber OM, Lipton L, Crabtree M, et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003;348:791-9.
17. Fusaro RM, Lemon SJ, Lynch HT. Muir-Torre syndrome and defective DNA mismatch repair genes. J Am Acad Dermatol 1996;35:493-4.
18. De Felice C, Latini G, Bianciardi G, et al. Abnormal vascular network complexity: a new phenotypic marker in hereditary non-polyposis colorectal cancer syndrome. Gut 2003;52:000-0.
19. Cross SS. Fractals in pathology. J Pathol 1997;182:1-8.
20. Baish JW, Jain RK. Fractals and cancer. Cancer Res 2000;60:3683-8.
21. Coffey DS. Self-organization, complexity and chaos: the new biology for medicine. Nat Med 1998;4:882-5.
22. Esgiar AN, Naguib RN, Sharif BS, et al. Fractal analysis in the detection of colonic cancer images. IEEE Trans Inf Technol Biomed 2002;6:54-8.
23. Waliszewski P, Molski M, Konarski J. On the holistic approach in cellular and cancer biology: nonlinearity, complexity, and quasi-determinism of the dynamic cellular network. J Surg Oncol 1998;68:70-8.
24. Kim YL, Liu Y, Wali RK, et al. Simultaneous measurement of angular and spectral properties of light scattering for the charterization of tissue microarchitecture and its alterations in early precancer. IEEE J Select Topics Quant Elec 2003 (in press).
25. Smyrk TC, Watson P, Kaul K, et al. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer 2001;91:2417-22.
26. Losi L, Fante R, Di Gregorio C, et al. Biologic characterization of hereditary non-polyposis colorectal cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. Am J Clin Pathol 1995;103:265-70.
27. Shimodaira H, Yoshioka-Yamashita A, Kolodner RD, et al. Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin. Proc Natl Acad Sci U S A 2003;100:2420-5.
28. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003;300:1155-9.